InsiderTrades

Form 4 for MET MetLife

Accepted 2024-02-29 00:00:00 ET · period of report 2024-02-27 · accession 0001099219-24-000052 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-02-29 2024-02-27 MET PAPPAS BILL EVP, Gbl Tech, Ops F - Tax $69.16 -30.0K 89.2K -25% -$2.07M
DM 2024-02-29 2024-02-27 MET PAPPAS BILL EVP, Gbl Tech, Ops A - Grant — +72.3K 56.2K New —
D 2024-02-29 2024-02-27 MET PAPPAS BILL EVP, Gbl Tech, Ops A - Grant $0.00 +28.0K 28.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-27 F D 29,959 $69.16 89,201 D — —
2 Common Common Stock 2024-02-27 A A 62,924 — 119,160 D — — (F3) Shares acquired from the determination of the performance factor for and payout of 2021-2023 performance shares under the MetLife, Inc. 2015 Stock and Incentive Compensation.
3 Common Common Stock 2024-02-27 A A 9,327 — 56,236 D — — (F1) Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. (F2) On November 15, 2023, 7,400 shares were distributed to the reporting person in accordance with the terms of the 2022 GRAT, and are now reported as directly owned.
4 Derivative Employee Stock Options (right to buy) 2024-02-27 A A 27,983 $0.00 27,983 D $69.16 · — to 2034-02-26 27,983 Common Stock (F5) The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date.